Skip to content

Clinical trials

Completed Phase 2 Lymphoma, T-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 2 Status: Completed Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20063
20072
20083
20094
20102
20115
20133
20141
20152
20161
20172
20187
20193

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
National Cancer Institute (NCI)3
Fred Hutchinson Cancer Center2
Masonic Cancer Center, University of Minnesota2
Samsung Medical Center2
The Lymphoma Academic Research Organisation2
AHS Cancer Control Alberta1
Acrotech Biopharma Inc.1
BeiGene1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell42
Lymphoma11
Hodgkin Disease8
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma, Mantle-Cell8
Lymphoma, B-Cell7
Lymphoma, Non-Hodgkin7
Lymphoma, T-Cell, Peripheral7
Leukemia, Myeloid, Acute6
Lymphoma, Follicular6

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.